Confirming the hypothesis that the increase in SIRT2 observed in the CNS with aging is harmful, numerous studies have also shown that its expression is also increased in different neurodegenerative diseases and that its genetic deletion or pharmacological inhibition provides beneficial effects in these conditions (Figure 2). The gene discussed is SIRT2; the disease is neurodegenerative disease.